Julie Hambleton
Board Member
Erasca, Inc. (ERAS)Equibles does not estimate personal net worth.
Get an email with a short summary when Erasca, Inc. publishes a filing, an earnings call transcript or a press release.
Get ERAS alertsAbout Julie Hambleton
Julie Hambleton is recorded as Board Member at Erasca, Inc. (ERAS). The newest filing on record that lists Julie Hambleton as Board Member at Erasca, Inc. (ERAS) is dated April 28, 2026. The proxy statement of IDEAYA Biosciences, Inc. reports total compensation of $686,726 for Julie Hambleton in fiscal 2019, including a base salary of $387,063. Disclosed compensation is on record for 2 fiscal years. Erasca, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Erasca, Inc. includes Jonathan Lim (CEO), David Chacko (CFO), Ebun S. Garner (General Counsel) and 7 others.
Affiliation history
-
Current
Start not stated–present
Last confirmed April 28, 2026
-
IDEAYA Biosciences, Inc. (IDYA)
Proxy statement
Start not stated–2020-04-30
Company network
Leadership on record at Erasca, Inc.
- Jonathan Lim CEO
- David Chacko CFO
- Ebun S. Garner General Counsel
- Alexander W. Casdin Board Member
- James A. Bristol Board Member
- Jean I. Liu Board Member
- Jean Liu, J.D. Board Member
- Michael D. Varney Board Member
- Pratik S. Multani Board Member
- Valerie Harding-Start Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2019 | IDEAYA Biosciences, Inc. (IDYA) | Senior Vice President and Chief Medical Officer, Head of Development | $387,063 | $686,726 |
| 2018 | IDEAYA Biosciences, Inc. (IDYA) | Senior Vice President and Chief Medical Officer, Head of Development | $218,750 | $797,642 |
Recent activity
No call appearances or filed executive changes recorded yet.